Breaking News Instant updates and real-time market news.

KSS

Kohl's

$79.10

0.86 (1.10%)

21:53
09/03/18
09/03
21:53
09/03/18
21:53

Kohl's initiated with a Buy at Goldman Sachs

Goldman Sachs started Kohl's with a Buy rating and $91 price target. The firm initiated the Apparel & Accessories space with an Attractive view on department stores and off-price retailers.

KSS Kohl's
$79.10

0.86 (1.10%)

08/22/18
MKMP
08/22/18
NO CHANGE
Target $81
MKMP
Neutral
Kohl's price target raised to $81 from $63 at MKM Partners
MKM Partners analyst Patrick McKeever raised his price target on Kohl's to $81 after a "very good" Q2, saying its comps were modestly better than expected and gross margins were strong as the company maintained a "lean inventory" in the quarter. While acknowledging that he missed the stock's 45% year-to-date run, McKeever adds that he remains concerned about Kohl's store traffic which he estimates to be negative. The analyst also anticipates comps to slow in the second half of the year against more difficult compares, keeping his Neutral rating on Kohl's.
08/22/18
RBCM
08/22/18
NO CHANGE
Target $82
RBCM
Sector Perform
Kohl's price target raised to $82 from $69 at RBC Capital
RBC Capital analyst Brian Tunick raised his price target on Kohl's to $82 after its "robust" Q2 results and "strong" comps thanks to the company's product and marketing initiatives along with a gross margin recovery coming from its "tight inventory management". The analyst states that he is more confident in Kohl's ongoing sales improvements and favorable macro environment combining to achieve an upside to the company's guidance. Tunick also keeps a Sector Perform rating on the shares, noting that the growing "secular pressures make a more meaningful comp recovery unlikely".
08/23/18
MSCO
08/23/18
NO CHANGE
Target $51
MSCO
Underweight
Kohl's price target raised to $51 from $45 at Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger maintained an Underweight rating on Kohl's but raised her price target to $51 from $45 following the company's Q2 earnings report, telling investors in a research note that Kohl's delivered an "excellent" 12 EPS beat, and its "clean" inventory bodes well for gross margin going forward. However, Greenberger wonders whether management set the comp bar too high for the second half of the year and is concerned about the lack of traffic growth driving the comp.
08/29/18
BARD
08/29/18
NO CHANGE
Target $27
BARD
Outperform
Under Armour selloff on Dick's 'head fake' a buying opportunity, says Baird
Baird analyst Jonathan Komp noted that while Dick's Sporting Goods (DKS) reported its own "disappointing" earnings, the company called out continued sales challenges for Under Armour (UAA), which it attributed to expanded distribution. He believes current sporting goods disruption for Under Armour is already reflected in the company's 2018 earnings guidance and also believes other mid-tier channels have continued to show strong sales performance, pointing out that Kohl's (KSS) saw Under Armour accelerate in Q2. Komp, who views the selloff on Dick's comments a "compelling buying opportunity," keeps an Outperform rating and $27 price target on Under Armour Class A shares.

TODAY'S FREE FLY STORIES

VKTX

Viking Therapeutics

$8.62

-0.15 (-1.71%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$41.52

-0.7 (-1.66%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Periodicals
U.S China trade negotators seek resolution of Micron-Fujian Jinhua spat, FT says »

U.S. and Chinese trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

XOM

Exxon Mobil

$77.84

-0.7 (-0.89%)

, MSFT

Microsoft

$109.47

2.27 (2.12%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Hot Stocks
Exxon Mobil partners with Microsoft to increase Permian profitability »

ExxonMobil (XOM) said a…

XOM

Exxon Mobil

$77.84

-0.7 (-0.89%)

MSFT

Microsoft

$109.47

2.27 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

EQ

Equillium

$5.76

-0.56 (-8.86%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Initiation
Equillium initiated  »

Equillium initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$18.13

-0.99 (-5.18%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Hot Stocks
Yext doubles workforce in France, names Selwa Hussain as EMEA CFO »

Yext announced the growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

ORTX

Orchard Therapeutics

$16.00

(0.00%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Hot Stocks
Orchard Therapeutics presents follow-up data from OTL-101 trial »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRVB

Provention Bio

$2.42

0.09 (3.86%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Initiation
Provention Bio initiated  »

Provention Bio initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.45

-0.025 (-1.70%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Initiation
MannKind initiated  »

MannKind initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

DERM

Dermira

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Dermira initiated  »

Dermira initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MDGL

Madrigal Pharmaceuticals

$125.62

2.5 (2.03%)

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 19

    Mar

ICPT

Intercept

$91.83

-7.17 (-7.24%)

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

NTRA

Natera

$16.00

-0.17 (-1.05%)

09:02
02/22/19
02/22
09:02
02/22/19
09:02
Hot Stocks
Natera's dd-cfDNA test shows 'superior performance' in study »

Natera announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

09:02
02/22/19
02/22
09:02
02/22/19
09:02
Syndicate
Trillium Therapeutics 18.75M share Spot Secondary priced at 80c »

Cowen acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

09:01
02/22/19
02/22
09:01
02/22/19
09:01
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$38.37

-0.76 (-1.94%)

, TSLA

Tesla

$291.18

-11.33 (-3.75%)

09:01
02/22/19
02/22
09:01
02/22/19
09:01
Periodicals
AutoNation CEO says Elon Musk acts in 'almost unethical way', CNBC reports »

AutoNation (AN) outgoing…

AN

AutoNation

$38.37

-0.76 (-1.94%)

TSLA

Tesla

$291.18

-11.33 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 27

    Feb

  • 18

    Mar

  • 19

    Mar

GLPG

Galapagos NV

$97.83

-3.2 (-3.17%)

09:00
02/22/19
02/22
09:00
02/22/19
09:00
Initiation
Galapagos NV initiated  »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

KL

Kirkland Lake Gold

$36.03

2.6 (7.78%)

08:59
02/22/19
02/22
08:59
02/22/19
08:59
Downgrade
Kirkland Lake Gold rating change  »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CBAY

CymaBay

08:59
02/22/19
02/22
08:59
02/22/19
08:59
Initiation
CymaBay initiated  »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIN

Albany International

$76.37

-0.285 (-0.37%)

08:58
02/22/19
02/22
08:58
02/22/19
08:58
Initiation
Albany International initiated  »

Albany International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

ATRS

Antares Pharma

$3.21

0.01 (0.31%)

08:58
02/22/19
02/22
08:58
02/22/19
08:58
Recommendations
Antares Pharma analyst commentary  »

Antares Pharma upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$0.62

-0.0047 (-0.75%)

, BMY

Bristol-Myers

$50.15

-1.14 (-2.22%)

08:57
02/22/19
02/22
08:57
02/22/19
08:57
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

AVEO

Aveo Pharmaceuticals

$0.62

-0.0047 (-0.75%)

BMY

Bristol-Myers

$50.15

-1.14 (-2.22%)

EXEL

Exelixis

$21.22

(0.00%)

IMMU

Immunomedics

$14.33

-0.03 (-0.21%)

JNJ

Johnson & Johnson

$135.40

-0.91 (-0.67%)

MRK

Merck

$79.82

0.38 (0.48%)

NKTR

Nektar

$40.26

-2.76 (-6.42%)

PFE

Pfizer

$42.14

-0.07 (-0.17%)

SGEN

Seattle Genetics

$69.25

-0.53 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

  • 11

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

08:55
02/22/19
02/22
08:55
02/22/19
08:55
Hot Stocks
Breaking Hot Stocks news story on Trillium Therapeutics »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GE

General Electric

$10.03

-0.07 (-0.69%)

, LLY

Eli Lilly

$122.72

0.05 (0.04%)

08:55
02/22/19
02/22
08:55
02/22/19
08:55
Options
Notable open interest changes for February 22nd »

Thursday's total…

GE

General Electric

$10.03

-0.07 (-0.69%)

LLY

Eli Lilly

$122.72

0.05 (0.04%)

TSLA

Tesla

$291.18

-11.33 (-3.75%)

ELAN

Elanco

$29.07

-0.29 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

  • 18

    Mar

  • 19

    Mar

  • 18

    May

PLAN

Anaplan

08:54
02/22/19
02/22
08:54
02/22/19
08:54
Recommendations
Anaplan analyst commentary  »

Anaplan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

ZG

Zillow

$35.07

0.22 (0.63%)

, Z

Zillow

$35.03

0.22 (0.63%)

08:54
02/22/19
02/22
08:54
02/22/19
08:54
Recommendations
Zillow, Zillow analyst commentary  »

Zillow core business…

ZG

Zillow

$35.07

0.22 (0.63%)

Z

Zillow

$35.03

0.22 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.